Trial no.:
|
PACTR2009100001631792 |
Date of Approval:
|
12/10/2009 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Efficacy of a glucose bolus versus glucose plus insulin in the treatment of hyperkalaemia |
Official scientific title |
Efficacy of a glucose bolus versus glucose plus insulin in the treatment of hyperkalaemia |
Brief summary describing the background
and objectives of the trial
|
Hyperkalaemia is a medical emergency which can lead to life-threatening cardiac arrhythmias. The principles of treatment include shifting potassium into cells using insulin plus glucose, ß2-agonists or sodium bicarbonate.
Hypoglycaemia is a common side effect of insulin therapy for hyperkalaemia and this study investigates whether an intravenous glucose bolus alone will cause sufficient endogenous insulin secretion to shift potassium into cells to a clinically useful degree. |
Type of trial |
CCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Hyperkalaemia,Nutritional, Metabolic, Endocrine |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
09/10/2009 |
Actual trial start date |
|
Anticipated date of last follow up |
18/10/2010 |
Actual Last follow-up date |
18/10/2010 |
Anticipated target sample size (number of participants) |
0 |
Actual target sample size (number of participants) |
|
Recruitment status |
Completed |
Publication URL |
http://www.karger.com/Article/Abstract/358836 |
|